Management of paroxysmal nocturnal hemoglobinuria in CALR mutated post‐essential thrombocythemia myelofibrosis: A case report
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Mahija Cheekati, KarLeung Siu, Rachel Ochs |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Targeted management of coexistent severe thrombophilias—A case report of a successful pregnancy despite paroxysmal nocturnal hemoglobinuria and hereditary protein C deficiency
by: Julien Dereme, et al.
Published: (2024)
by: Julien Dereme, et al.
Published: (2024)
IDH2 mutation accelerates TPO‐induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo
by: Chien‐Chin Lin, et al.
Published: (2024)
by: Chien‐Chin Lin, et al.
Published: (2024)
RUNX1::CBFA2T2 rearranged acute myeloid leukemia transformed from JAK2 V617F mutated primary myelofibrosis
by: Lina Han, et al.
Published: (2024)
by: Lina Han, et al.
Published: (2024)
From primary myelofibrosis to chronic myeloid leukemia, BCR::ABL1+ B‐Lymphoblastic leukemia, and back to primary myelofibrosis: An illustration of dynamic clonal evolution
by: Devin Wang, et al.
Published: (2024)
by: Devin Wang, et al.
Published: (2024)
Impact of secondary‐type mutations in acute myeloid leukemia with CEBPA mutation
by: Davidson Zhao, et al.
Published: (2024)
by: Davidson Zhao, et al.
Published: (2024)
Fatal drug reaction to andexanet alfa: a case report
by: Richard J. Buka, et al.
Published: (2024)
by: Richard J. Buka, et al.
Published: (2024)
Aleukemic congenital leukemia cutis preceding monocytic leukemia with favorable outcome: A case report
by: Caroline Lo Presti, et al.
Published: (2024)
by: Caroline Lo Presti, et al.
Published: (2024)
Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: A matched‐cohort analysis
by: Michael R. Grunwald, et al.
Published: (2024)
by: Michael R. Grunwald, et al.
Published: (2024)
Novel BRAF N581S mutation in mantle cell lymphoma
by: Nisha Hariharan, et al.
Published: (2024)
by: Nisha Hariharan, et al.
Published: (2024)
Iatrogenic hemorrhage and extensive venous thromboembolism during iTTP treatment with caplacizumab—A case report
by: Erik Boberg, et al.
Published: (2024)
by: Erik Boberg, et al.
Published: (2024)
CD4+ chronic lymphocytic leukemia in an 86‐year‐old male veteran: A case report
by: Sara Abdelrahim, et al.
Published: (2024)
by: Sara Abdelrahim, et al.
Published: (2024)
MYD88‐mutated Lymphoplasmacytic Lymphoma With Monoclonal Immunoglobulin G: A Case Report
by: Morten Yung Isaksen, et al.
Published: (2025)
by: Morten Yung Isaksen, et al.
Published: (2025)
Extramedullary chronic phase chronic myeloid leukaemia (CML) involving the central nervous system: A case report
by: Akshay Deshpande, et al.
Published: (2024)
by: Akshay Deshpande, et al.
Published: (2024)
Impact of HFE mutations on thrombotic risk in patients with idiopathic erythrocytosis: A single‐centre study
by: Irene Bertozzi, et al.
Published: (2024)
by: Irene Bertozzi, et al.
Published: (2024)
Intravenous Immunoglobulin offers temporary improvement in acquired von Willebrand syndrome due to monoclonal gammopathy: A case report
by: Kevin G. Zablonski, et al.
Published: (2024)
by: Kevin G. Zablonski, et al.
Published: (2024)
Sequential treatment with valemetostat and conventional anti‐cancer drugs for refractory aggressive adult T‐cell leukemia/lymphoma: A case report
by: Kosuke Obama, et al.
Published: (2024)
by: Kosuke Obama, et al.
Published: (2024)
Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma – A case report
by: Anna Nikkarinen, et al.
Published: (2024)
by: Anna Nikkarinen, et al.
Published: (2024)
CD117 expression predicted FLT3 mutation in T‐cell acute lymphoblastic leukemia
by: Haijin Wang, et al.
Published: (2024)
by: Haijin Wang, et al.
Published: (2024)
Antiphospholipid syndrome, monoclonal gammopathy, and cryoglobulinemia overlap leading to recurrent cutaneous microvascular thrombosis: A case report and retrospective cohort study
by: Alexandra Bohm, et al.
Published: (2024)
by: Alexandra Bohm, et al.
Published: (2024)
Effective treatment of relapsed/refractory CD19‐positive B/T‐type mixed‐phenotype acute leukemia with blinatumomab: A case report
by: Masanori Aoki, et al.
Published: (2024)
by: Masanori Aoki, et al.
Published: (2024)
Successful treatment of low‐risk myelodysplastic syndrome‐related anemia in patients with chronic kidney disease with daprodustat: A report of two cases
by: Hiroyoshi Kunimoto, et al.
Published: (2024)
by: Hiroyoshi Kunimoto, et al.
Published: (2024)
Successful treatment of refractory donor‐specific‐human leukocyte antigen‐antibody‐induced primary graft‐failure with daratumumab: A case report
by: Vadim Lesan, et al.
Published: (2024)
by: Vadim Lesan, et al.
Published: (2024)
Atypical meningeal localization of classical hairy cell leukemia with an impressive response to rituximab and cladribine association. A case report and literature review
by: Fabien Claves, et al.
Published: (2024)
by: Fabien Claves, et al.
Published: (2024)
Bleeding management in type 3 von Willebrand disease with anti‐von Willebrand factor inhibitor: A literature review and case report
by: Aurélie Briane, et al.
Published: (2024)
by: Aurélie Briane, et al.
Published: (2024)
Dramatically elevated plasma vascular endothelial growth factor levels from influenza A infection in polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome: A case report
by: Ashwin Kannan, et al.
Published: (2024)
by: Ashwin Kannan, et al.
Published: (2024)
Central nervous system posttransplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation successfully treated with combination therapy of acalabrutinib and immunochemotherapy: A case report and literature review
by: Peihao Zheng, et al.
Published: (2024)
by: Peihao Zheng, et al.
Published: (2024)
Myeloid neoplasm post cytotoxic treatment in patients with multiple myeloma
by: Ke Xu, et al.
Published: (2024)
by: Ke Xu, et al.
Published: (2024)
Low‐dose decitabine plus venetoclax as post‐transplant maintenance for high‐risk myeloid malignancies
by: Katherine Parks, et al.
Published: (2024)
by: Katherine Parks, et al.
Published: (2024)
Emicizumab for acquired hemophilia A: Report of two cases and dosing strategies
by: Faiza Ahmed, et al.
Published: (2024)
by: Faiza Ahmed, et al.
Published: (2024)
Acute myeloid leukemia with RAM immunophenotype: A report of three patients and comprehensive literature review
by: Xenia Parisi, et al.
Published: (2025)
by: Xenia Parisi, et al.
Published: (2025)
Venetoclax in the Therapeutic Strategy for BPDCN Management
by: Margaux Poussard, et al.
Published: (2025)
by: Margaux Poussard, et al.
Published: (2025)
Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report
by: Jasmine Naru, et al.
Published: (2024)
by: Jasmine Naru, et al.
Published: (2024)
A case of benign immunoglobulin D monoclonal gammopathy of undetermined significance with 26 years of follow‐up
by: Larry D. Anderson, et al.
Published: (2024)
by: Larry D. Anderson, et al.
Published: (2024)
Appropriate Management of Thrombotic Risk in Patients With Primary Immune Thrombocytopenia in the UK: A Modified Delphi Consensus
by: Charlotte Bradbury, et al.
Published: (2025)
by: Charlotte Bradbury, et al.
Published: (2025)
Evaluating Economic and Clinical Impacts of Anaemia Management Strategies: A Systematic Review of the Evidence From the UK Perspective
by: Hiro Farabi, et al.
Published: (2025)
by: Hiro Farabi, et al.
Published: (2025)
Real World Management of Cytopenias and Infections in Patients With Myelofibrosis Treated With Ruxolitinib
by: Liesl A. Butler, et al.
Published: (2025)
by: Liesl A. Butler, et al.
Published: (2025)
Physician Survey on the Management of Pulmonary Embolism in Pregnancy: Need for Guidance and Training
by: Giulia Simini, et al.
Published: (2025)
by: Giulia Simini, et al.
Published: (2025)
Warm Autoimmune Haemolytic Anaemia Management in Asia‐Pacific: A Delphi Panel Expert Consensus and Systematic Literature Review
by: Phil Choi, et al.
Published: (2025)
by: Phil Choi, et al.
Published: (2025)
Safety, Efficacy, and Patient‐Reported Outcomes From a Phase 2 Randomized Trial of Pozelimab and Cemdisiran Combination in Patients With Paroxysmal Nocturnal Hemoglobinuria
by: Jun‐Ho Jang, et al.
Published: (2025)
by: Jun‐Ho Jang, et al.
Published: (2025)
Safety and Efficacy of Busulphan Based on Dosing Patterns in the Real‐World Management of Myeloproliferative Neoplasms
by: Ali Mahdi, et al.
Published: (2025)
by: Ali Mahdi, et al.
Published: (2025)
Similar Items
-
Targeted management of coexistent severe thrombophilias—A case report of a successful pregnancy despite paroxysmal nocturnal hemoglobinuria and hereditary protein C deficiency
by: Julien Dereme, et al.
Published: (2024) -
IDH2 mutation accelerates TPO‐induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo
by: Chien‐Chin Lin, et al.
Published: (2024) -
RUNX1::CBFA2T2 rearranged acute myeloid leukemia transformed from JAK2 V617F mutated primary myelofibrosis
by: Lina Han, et al.
Published: (2024) -
From primary myelofibrosis to chronic myeloid leukemia, BCR::ABL1+ B‐Lymphoblastic leukemia, and back to primary myelofibrosis: An illustration of dynamic clonal evolution
by: Devin Wang, et al.
Published: (2024) -
Impact of secondary‐type mutations in acute myeloid leukemia with CEBPA mutation
by: Davidson Zhao, et al.
Published: (2024)